Subscribe To
Syros pharmaceuticals undergoes leadership shakeup, workforce reduction
Syros Pharmaceuticals shares dropped on Monday after a series of shakeups at the biotech company. The f...
October 2, 2023, 4:09 pm
3 promising biotech stocks that will make early investors rich
For investment ideas that can potentially lead to life-changing gains, few sectors are as viable as biotech ...
October 2, 2023, 3:07 pm
Stable giants: 3 bigwig biotech stocks for consistent returns
biotech stocks have had a rough post-pandemic. In a year where the S&P500 is up more than 10% year to d...
October 2, 2023, 11:28 am
5 top stocks for october
These five stocks could hardly be more different, but they have one important thing in common: All look like great buys in October 2023. From retail t...
October 1, 2023, 9:09 am
Cidara therapeutics reports inducement grant under nasdaq listing rule 5635(c)(4)
SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® pl...
September 29, 2023, 8:51 pm
Goldman sachs' chris shibutani talks his top biotech picks including eli lilly and pfizer
Chris Shibutani, Goldman Sachs Senior Analyst, joins 'Closing Bell Overtime' to talk his top picks in the biot...
September 29, 2023, 5:43 pm
Labu and labd: another attractive double-short pairs trade
Pairing Direxion Daily's S&P biotech Bull 3X Shares ETF with their S&P ...
September 29, 2023, 4:50 pm
Biogen gets fda approval for biotech treatment similar to roche's actemra
Biogen Inc. BIIB, -0.32% said late Friday the Food and Drug Administration approved its biosimilar version of Roche ROG, +0.30% ‘s arthritis treatme...
September 29, 2023, 4:25 pm
Psychedelics m&a heating up as one drug nears fda-approval
With MDMA on track to gain United States Food and Drug Administration (FDA) approval for the treatment of post-traumatic stress disorder (PTSD) in 202...
September 29, 2023, 3:26 pm
Maravai lifesciences hosts 2023 investor r&d day
Highlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlook SAN DIEGO, Sept. 29, 2023 (GLOBE...
September 29, 2023, 12:15 pm
Shares of biotech startup structure therapeutics surge more than 30% on promising obesity pill data
Structure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy....
September 29, 2023, 12:02 pm
Capricor therapeutics announces $23 million registered direct offering
SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformat...
September 29, 2023, 11:35 am
Dyadic to present at industry and investor events in october
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo...
September 29, 2023, 8:30 am
Is ishares biotechnology etf (ibb) a strong etf right now?
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Healt...
September 29, 2023, 7:31 am
Alexandria and realty income: my current 2 biggest 'buys'
Investing in out-of-favor sectors can lead to good deals. The REIT sector is currently out of favor due to various reasons. Alexandria Real Estate is ...
September 29, 2023, 5:29 am
Why is baudax bio (bxrx) stock up 75% today?
As the market attempted to recover from a recent series of disappointing performances, biotechnology firm Baudax Bio (NASDAQ: BXRX ) represented a dra...
September 28, 2023, 1:07 pm
Undervalued biotech stocks shine: pfizer and biontech show resilience
In the ever-evolving world of the stock market, uncovering potential gold mines is paramount for smart investing. One promising area to consider is un...
September 28, 2023, 11:23 am
Is biogen stock a buy now?
Biogen has faced a series of frustrations in its research efforts efforts in recent years. The biotech ...
September 28, 2023, 10:07 am
Kineta announces participation at october investor conferences
SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...
September 28, 2023, 9:30 am
3 biotech stocks to watch ahead of potential obesity drug approvals
The companies that already have obesity drugs can't keep up with the demand for their treatments, and the demand for the drugs is only likely to becom...
September 28, 2023, 8:45 am